P2Y2 receptor-stimulated phosphoinositide hydrolysis and Ca2+ mobilization in tracheal epithelial cells

被引:6
作者
Yang, CM [1 ]
Wu, WB [1 ]
Pan, SL [1 ]
Tsai, YJ [1 ]
Chiu, CT [1 ]
Wang, CC [1 ]
机构
[1] Chang Gung Univ, Coll Med, Dept Pharmacol, Cellular & Mol Pharmacol Lab, Tao Yuan, Taiwan
关键词
canine; inositol phosphates; purinergic receptors; adenosine 5 '-triphosphate;
D O I
10.1152/ajplung.2000.279.2.L235
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Extracellular nucleotides have been implicated in the regulation of secretory function through the activation of P2 receptors in the epithelial tissues, including tracheal epithelial cells (TECs). In this study, experiments were conducted to characterize the P2 receptor subtype on canine TECs responsible for stimulating inositol phosphate (InsP(x)) accumulation and Ca2+ mobilization using a range of nucleotides. The nucleotides ATP and UTP caused a concentration-dependent increase in [H-3]InsP(x) accumulation and Ca2+ mobilization with comparable kinetics and similar potency. The selective agonists for P1, P2X, and P2Y(1) receptors, N-6-cyclopentyladenosine and AMP, alpha,beta-methylene-ATP and beta,gamma-methylene-ATP, and 2-methylthio-ATP, respectively, had little effect on these responses. Stimulation of TECs with maximally effective concentrations of ATP and UTP showed no additive effect on [H-3]InsP(x) accumulation. The response of a maximally effective concentration of either ATP or UTP was additive to the response evoked by bradykinin. Furthermore, ATP and UTP induced a cross-desensitization in [H-3]InsP(x) accumulation and Ca2+ mobilization. These results suggest that ATP and UTP directly stimulate phospholipase C-mediated [H-3]InsP(x) accumulation and Ca2+ mobilization in canine TECs. P2Y(2) receptors may be predominantly mediating [H-3]InsP(x) accumulation, and, subsequently, inositol 1,4,5-trisphosphate-induced Ca2+ mobilization may function as the transducing mechanism for ATP-modulated secretory function of tracheal epithelium.
引用
收藏
页码:L235 / L241
页数:7
相关论文
共 40 条
  • [1] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [2] G-PROTEIN-COUPLED P-2 PURINOCEPTORS - FROM MOLECULAR-BIOLOGY TO FUNCTIONAL-RESPONSES
    BOARDER, MR
    WEISMAN, GA
    TURNER, JT
    WILKINSON, GF
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (04) : 133 - 139
  • [3] BROWN HA, 1991, MOL PHARMACOL, V40, P648
  • [4] IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR
    BURNSTOCK, G
    KENNEDY, C
    [J]. GENERAL PHARMACOLOGY, 1985, 16 (05): : 433 - 440
  • [5] The past, present and future of purine nucleotides as signalling molecules
    Burnstock, G
    [J]. NEUROPHARMACOLOGY, 1997, 36 (09) : 1127 - 1139
  • [6] Cloning, functional expression and tissue distribution of the human P2Y(6) receptor
    Communi, D
    Parmentier, M
    Boeynaems, JM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 222 (02) : 303 - 308
  • [7] Pharmacological characterization of the human P-2Y4 receptor
    Communi, D
    Motte, S
    Boeynaems, JM
    Pirotton, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 317 (2-3) : 383 - 389
  • [8] Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase
    Communi, D
    Govaerts, C
    Parmentier, M
    Boeynaems, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 31969 - 31973
  • [9] DALZIEL HH, 1994, PHARMACOL REV, V46, P449
  • [10] FREDHOLM BB, 1994, PHARMACOL REV, V46, P143